← All trials
NCT03740529
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 16, 2018
- Primary completion
- Oct 31, 2020
- Completion date
- Apr 30, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 190
- Arms / groups
- 7 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Loxo OncologyLead sponsor
- Loxo OncologyStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.